Liver-specific reactivation of the inactivated Hnf-1α gene:: Elimination of liver dysfunction to establish a mouse MODY3 model

被引:11
|
作者
Lee, YH [1 ]
Magnuson, MA
Muppala, V
Chen, SS
机构
[1] Acad Sinica, Inst Mol Biol, Lab Mol Pathol, Taipei 115, Taiwan
[2] Natl Def Med Ctr, Grad Inst Life Sci, Taipei 100, Taiwan
[3] Vanderbilt Univ, Sch Med, Dept Mol Physiol & Biophys, Nashville, TN 37233 USA
[4] Vanderbilt Univ, Sch Med, Dept Med, Nashville, TN 37233 USA
关键词
D O I
10.1128/MCB.23.3.923-932.2003
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Mice deficient in hepatocyte nuclear factor 1 alpha (HNF-1alpha) develop dwarfism, liver dysfunction, and type 2 diabetes mellitus. Liver dysfunction in HNF-1alpha-null mice includes severe hepatic glycogen accumulation and dyslipidemia. The liver dysfunction may appear as soon as 2 weeks after birth. Since the HNF-1alpha-null mice become diabetic 2 weeks after birth, the early onset of the liver dysfunction is unlikely to be due to the diabetic status of the mice. More likely, it is due directly to the deficiency of HNF-1alpha in liver. Although the HNF-1alpha-null mice have an average life span of I year, the severe liver phenotype has thwarted attempts to study the pathogenesis of maturity-onset diabetes of the young type 3 (MODY3) and to examine therapeutic strategies for diabetes prevention and treatment in these mice. To circumvent this problem, we have generated a new Hnf-1alpha mutant mouse line, Hnf-1alpha(kin/kin), using gene targeting to inactivate the Hnf-1alpha gene and at the same time, to incorporate the Cre-loxP DNA recombination system into the locus for later revival of the Hnf-1alpha gene in tissues by tissue-specifically expressed Cre recombinase. The Hnf-1alpha(kin/kin) mice in which the expression of HNF-1alpha was inactivated in germ line cells were indistinguishable from the HNF-1alpha-null mice with regard to both the diabetes and liver phenotypes. Intriguingly, when the inactivated Hnf-1alpha gene was revived in liver (hepatic Hnf-1alpha revived) by the Cre recombinase driven by an albumin promoter, the Hnf-1alpha(kin/kin). mice, although severely diabetic, grew normally and did not develop any of the liver dysfunctions. In addition, we showed that the expression of numerous genes in pancreas, including a marker gene for pancreas injury, was affected by liver dysfunction but not by the deficiency of HNF-1alpha in pancreas. Thus, our hepatic-Hnf-1alpha-revived mice may serve as a useful mouse model to study the human MODY3 disorder.
引用
收藏
页码:923 / 932
页数:10
相关论文
共 50 条
  • [31] Life-long liver-specific AAV-mediated gene therapy in a Crigler-Najjar mouse model
    Bortolussi, G.
    Zentilin, L.
    Vanikova, J.
    Vianello, E.
    Mancarella, A.
    Bockor, L.
    Bellarosa, C.
    Tiribelli, C.
    Vitek, L.
    Giacca, M.
    Muro, A. F.
    HUMAN GENE THERAPY, 2013, 24 (12) : A133 - A133
  • [32] Interaction between STAT-3 and HNF-3 leads to the activation of liver-specific hepatitis B virus enhancer 1 function
    Waris, G
    Siddiqui, A
    JOURNAL OF VIROLOGY, 2002, 76 (06) : 2721 - 2729
  • [33] Highly Specific and Effective HCC Gene Therapy Based on Cancer-specific RNA Replacement via Liver-specific microRNA Regulation in Mouse Model
    Jeong, Jin Sook
    Han, Sang Young
    Lee, Seong-Wook
    Kim, In-Hoo
    HEPATOLOGY, 2012, 56 : 793A - 793A
  • [34] Abcb4-defect cholangitis mouse model with hydrophobic bile acid composition by in vivo liver-specific gene deletion
    Tsuruya, Kota
    Yokoyama, Keiko
    Mishima, Yusuke
    Ida, Kinuyo
    Araki, Takuma
    Ieda, Satsuki
    Ohtsuka, Masato
    Inagaki, Yutaka
    Honda, Akira
    Kagawa, Tatehiro
    Kamiya, Akihide
    JOURNAL OF LIPID RESEARCH, 2024, 65 (09)
  • [35] COMPLEX ORGANIZATION OF CTF/NF-I, C/EBP, AND HNF3 BINDING SITES WITHIN THE PROMOTER OF THE LIVER-SPECIFIC VITELLOGENIN GENE
    CARDINAUX, JR
    CHAPEL, S
    WAHLI, W
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1994, 269 (52) : 32947 - 32956
  • [36] Liver-specific DICER1 syndrome model mouse develops congenital hepatic fibrosis and Caroli's syndrome
    Ohno, Shinichiro
    Harada, Yuichirou
    Kuroda, Masahiko
    CANCER SCIENCE, 2024, 115 : 1139 - 1139
  • [37] Overexpression of liver-specific cytochrome P4502E1 impairs hepatic insulin signaling in a transgenic mouse model of nonalcoholic fatty liver disease
    Kathirvel, Elango
    Morgan, Kengathevy
    French, Samuel W.
    Morgan, Timothy R.
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2009, 21 (09) : 973 - 983
  • [38] Transcription factor HNF-6/OC-1 inhibits the stimulation of the HNF-3α/Foxa1 gene by TGF-β in mouse liver
    Plumb-Rudewiez, N
    Clotman, F
    Strick-Marchand, H
    Pierreux, CE
    Weiss, MC
    Rousseau, GG
    Lemaigre, FP
    HEPATOLOGY, 2004, 40 (06) : 1266 - 1274
  • [39] COMPETITION BETWEEN TRANSCRIPTION FACTORS HNF1 AND HNF3, AND ALTERNATIVE CELL-SPECIFIC ACTIVATION BY DBP AND C/EBP CONTRIBUTE TO THE REGULATION OF THE LIVER-SPECIFIC ALDOLASE-B PROMOTER
    GREGORI, C
    KAHN, A
    PICHARD, AL
    NUCLEIC ACIDS RESEARCH, 1993, 21 (04) : 897 - 903
  • [40] Severe Hepatic Insulin Resistance Induces Vascular Dysfunction: Improvement by Liver-Specific Insulin Receptor Isoform A Gene Therapy in a Murine Diabetic Model
    Gomez-Hernandez, Almudena
    de las Heras, Natalia
    Lopez-Pastor, Andrea R.
    Garcia-Gomez, Gema
    Infante-Menendez, Jorge
    Gonzalez-Lopez, Paula
    Gonzalez-Illanes, Tamara
    Lahera, Vicente
    Benito, Manuel
    Escribano, Oscar
    CELLS, 2021, 10 (08)